In re Immunex Securities litigation On behalf of Immunex stockholders, CMHT recovered $14 million, the largest securities class action settlement in Seattle. The lawsuit alleged that defendants concealed material adverse facts impacting Immunex's ability to achieve increasing profitability through the sale of its drug, Leukine.
Centrust Securities litigation This lawsuit alleged that, during a four-year period, CenTrust securities traded at artificially inflated levels as the result of false statements made by certain officers and directors of CenTrust, as well as CenTrust's outside auditor, regarding CenTrust's financial condition and business operations. After years of intensive litigation, CMHT was able to create a recovery of over $18 million for members of the Class.
Market Data 
Markets 
AI
